Quarter Financials
Aridis Pharmaceuticals, Inc. (ARDS)
$0.8503
-0.36 (-29.73%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Net Income | -8 | -8 | -10 | - | - | - | - | - |
|---|
| Dividend Paid | - | - | -0 | - | - | - | - | - |
|---|
| Retained Earnings | -181 | -173 | -165 | -156 | -135 | -130 | - | -117 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Capital Expenditure | -0 | -0 | 1 | -0 | -0 | -0 | -0 | -0 |
|---|
| Net PPE | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|